Your browser doesn't support javascript.
loading
Nanocurcumin as an adjuvant in killed Toxoplasma gondii vaccine formulation: An experience in BALB/c mice.
Mahdi Ghahari, Seyed Mohammad; Ajami, Abolghasem; Sadeghizadeh, Majid; Esmaeili Rastaghi, Ahmad Reza; Mahdavi, Mehdi.
Afiliación
  • Mahdi Ghahari SM; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Ajami A; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Department of Infectious Diseases, Antimicrobial Resistance Research Center, Mazandaran University o
  • Sadeghizadeh M; Department of Genetics, School of Biological Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: sadeghma@modares.ac.ir.
  • Esmaeili Rastaghi AR; Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: esma@pasteur.ac.ir.
  • Mahdavi M; Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran; Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran; Immunotherapy Group, The
Exp Parasitol ; 243: 108404, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36265591

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Toxoplasma / Adyuvantes Inmunológicos / Vacunas Antiprotozoos / Curcumina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Exp Parasitol Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Toxoplasma / Adyuvantes Inmunológicos / Vacunas Antiprotozoos / Curcumina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Exp Parasitol Año: 2022 Tipo del documento: Article País de afiliación: Irán